SARS CoV 2 News and Research

RSS

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

A new study published on the preprint server medRxiv in October 2020 reports the findings of a phase I trial of an inactivated SARS-CoV-2 vaccine, demonstrating that it can elicit a potent immune response without significant adverse reactions.

7 Oct 2020

Plasma ABO protein is a causal risk factor for severe COVID-19

Researchers used an integrative genomics approach to find the genes responsible for COVID-19 and its severity.

7 Oct 2020

Anosmia and ageusia may be useful as COVID-19 surveillance case definitions

A recent study published on the preprint server medRxiv in October 2020 reports the utility of alterations in taste and smell to monitor the prevalence of COVID-19 among contacts and in a community that lacks unlimited testing resources.

7 Oct 2020

Transmission dynamics of COVID-19 in two Indian states

Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, “Epidemiology and transmission dynamics of COVID-19 in two Indian states,” was published in the latest issue of the journal Science last week.

7 Oct 2020

Religion and risk of COVID-19 in UK

Their study titled, “Religious affiliation and the risk of COVID 19 related mortality; a retrospective analysis of variation in pre and post lockdown risk by religious group in England and Wales,” was published in the pre-publication site medRxiv.

7 Oct 2020

No rise in extremely preterm births during COVID-19 lockdown

Since the declaration of the COVID-19 pandemic, many countries have implemented restrictions on mobility and social interactions, including lockdowns. This has been associated with a reduction in the number of extremely preterm (EP) babies, according to one Danish study. A recent paper published on the preprint server medRxiv in October 2020 reveals that this may not be the case.

7 Oct 2020

Proteolytic cleavage of nucleocapsid helps SARS-CoV-2 evade host immune responses

A team of scientists of the University of Oxford reveals that the nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoes autoproteolysis, and that resulting products can escape the host immune responses and facilitate viral proliferation. The study is currently available on the bioRxiv preprint server.

7 Oct 2020

Study shows effective light-induced inactivation of SARS-CoV-2 with conjugated oligomers and polymers

A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.

7 Oct 2020

Rapid, low-cost test for potential universal COVID-19 monitoring

An international team of researchers has presented a convenient, low-cost serology test to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could potentially be made available universally.

7 Oct 2020

SARS-CoV-2 infection analysis could help fight against COVID-19

Researchers in the United States has provided a detailed catalog of the interactions that occur between host cell proteins and RNA and the RNA of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the course of infection.

7 Oct 2020

Researchers hope to develop an effective COVID-19 vaccine using bovine adenovirus

A researcher in Penn State's College of Agricultural Sciences is part of a team of scientists working to develop a unique COVID-19 vaccine that uses a bovine adenovirus as a safe and effective delivery vehicle.

7 Oct 2020

Case report of arthritis in a COVID-19 patient

The current paper published in the The Lancet Rheumatology discusses arthritis in a 58-year-old white woman with COVID-19 of less than severe intensity.

7 Oct 2020

Humans pose considerable risk in transmitting SARS-CoV-2 to wildlife

There's considerable risk that humans transmit SARS-CoV-2, the virus that causes COVID-19, to wildlife, according to a perspective article published in Mammal Review.

7 Oct 2020

People infected with other types of coronaviruses may have less severe COVID-19 infection

Being previously infected with a coronaviruses that cause the "common cold" may decrease the severity of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infections, according to results of a new study

7 Oct 2020

SARS-CoV-2 spike protein may induce analgesia

A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.

7 Oct 2020

Researchers quantify aerosols generated during anesthetic procedures

Since the outset of the COVID-19 pandemic, there has been much debate about the danger to hospital staff from anaesthetic procedures. Concerns include that placing a tube in the patient's airway (intubation) before surgery or removing it at the end (extubation) may produce a fine mist of small particles (called aerosols) and spread the COVID-19 virus to nearby staff.

7 Oct 2020